1. Home
  2. BSET vs PYXS Comparison

BSET vs PYXS Comparison

Compare BSET & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bassett Furniture Industries Incorporated

BSET

Bassett Furniture Industries Incorporated

HOLD

Current Price

$18.17

Market Cap

169.9M

ML Signal

HOLD

Logo Pyxis Oncology Inc.

PYXS

Pyxis Oncology Inc.

HOLD

Current Price

$3.38

Market Cap

141.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSET
PYXS
Founded
1902
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
169.9M
141.3M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
BSET
PYXS
Price
$18.17
$3.38
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.00
AVG Volume (30 Days)
15.0K
1.3M
Earning Date
04-01-2026
05-13-2026
Dividend Yield
5.49%
N/A
EPS Growth
163.06
3.03
EPS
0.37
N/A
Revenue
$456,855,000.00
$13,858,000.00
Revenue This Year
$1.72
N/A
Revenue Next Year
$3.78
$7,043.98
P/E Ratio
$49.11
N/A
Revenue Growth
0.96
N/A
52 Week Low
$13.17
$1.03
52 Week High
$22.26
$5.55

Technical Indicators

Market Signals
Indicator
BSET
PYXS
Relative Strength Index (RSI) 36.76 54.54
Support Level $14.13 $1.37
Resistance Level $19.43 $4.00
Average True Range (ATR) 0.55 0.33
MACD -0.08 0.03
Stochastic Oscillator 0.34 51.32

Price Performance

Historical Comparison
BSET
PYXS

About BSET Bassett Furniture Industries Incorporated

Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma. Its product candidate, micvotabart pelidotin (MICVO, formerly PYX-201), is an investigational antibody-drug conjugate that targets extradomain-B fibronectin (EDB+FN), a component of the tumor extracellular matrix that is expressed in tumors and minimally present in normal tissues. MICVO consists of a fully human monoclonal antibody linked to a microtubule inhibitor payload, designed to bind within the tumor microenvironment and release its payload to kill cancer cells directly, affect nearby cells through a bystander effect, and induce immunogenic cell death, supporting enhanced anti-tumor activity.

Share on Social Networks: